Pfizer Seeks To Stymie Sandoz, Accord’s Generic Torisel

Law360, New York (December 16, 2011, 8:05 PM EST) -- Pfizer Inc. on Thursday moved to protect its kidney cancer drug Torisel, filing a pair of lawsuits against Sandoz Inc. and Accord Healthcare Ltd. in response to the companies' petitions for regulatory approval of their generic versions of the drug.

Pfizer said in Delaware federal court that Sandoz and Accord are stealing Pfizer's patented injectable by filing generic drug applications with the U.S. Food and Drug Administration.

Sandoz and Accord have “committed, or aided, abetted, contributed to and/or participated in the commission of, the tortious action...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.